VUNO Med®-Chest X-ray™
VUNO
Product specifications |
Information source:
Vendor
Last updated: Aug. 26, 2021 |
General | |
---|---|
Product name | VUNO Med®-Chest X-ray™ |
Company | VUNO |
Subspeciality | Chest |
Modality | X-ray |
Disease targeted | Nodule/Mass, Consolidation, Interstitial Opacity, Pneumothorax, Pleural Effusion |
Key-features | Abnormality detection |
Suggested use | Before: adapting worklist order, flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion |
Data characteristics | |
Population | All population with a risk of thoracic abnormalities |
Input | Chest XR PA/AP images |
Input format | DICOM |
Output | Abnormality score, Lesion heatmap, Lesion boundary |
Output format | DICOM, GSPS |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | < 3 sec |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
No or not yet |
Market presence | |
On market since | 06-2020 |
Distribution channels | Arterys, Samsung Electronics |
Countries present (clinical, non-research use) | 10+ |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |
|